ACC 2022 Conference Coverage


 

ACC 2022: Long-term Safety and Tolerability of Acoramidis in Symptomatic Transthyretin Amyloid Cardiomyopathy

87 views
April 8, 2022
0 Comments
Login to view comments. Click here to Login
Videos